Box score
Arialys Therapeutics, Inc.
Reported $14.8M sold in a new Form D filed July 1, 2025 (La Jolla, California).
- Biggest raise
- $14.8M filed Jul 1, 2025
- League
- Bio & Health Biotechnology
- Based in
- La Jolla, California
- Season rank
- #242 of 1,311 in the Bio & Health League; #1565 of 12,397 overall (2025)
- Incorporated
- 2021
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2025-07-01 | New notice | $14.8M | $24.8M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1956823.
Similar raises, 2025
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Syndex Bio Inc. rookie | Bio & Health | $15.5M |
| 2 | OutcomeMD, Inc. | Bio & Health | $15.2M |
| 3 | Atraverse Medical, Inc. | Bio & Health | $15M |
| 4 | Enlaza Therapeutics, Inc. | Bio & Health | $15M |
| 5 | Celltrio, Inc. rookie | Bio & Health | $15M |
| 6 | Bright Uro, Inc. | Bio & Health | $14.7M |